Hoffmann-La Roche

Kate 3

NCT04740918

A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC)

Status:

Opening soon

26459-200.png

III

Phase

Line of Therapy.png

1st+

Line of Therapy

Disease Stage.png

Advanced / Metastatic

Disease Stage

Target.png

Biomarker(s)

HER2+, PD-L1

Investigational

Product

Atezolizumab

Treatment Arms

o Trastuzumab Emtansine and Placebo

o Trastuzumab Emtansine and Atezolizumab